Pharmacogenomics of anti-platelet and anti-coagulation therapy.

ABSTRACT: Arterial thrombosis is a major component of vascular disease, especially myocardial infarction (MI) and stroke. Current anti-thrombotic therapies such as warfarin and clopidogrel are effective in inhibiting cardiovascular events; however, there is great inter-individual variability in response to these medications. In recent years, it has been recognized that genetic factors play a significant role in drug response, and, subsequently, common variants in genes responsible for metabolism and drug action have been identified. These discoveries along with new diagnostic targets and therapeutic strategies hold promise for more effective individualized anti-coagulation and anti-platelet therapy.

SUBMITTER: Fisch AS 

PROVIDER: S-EPMC3809070 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature